Companies / Cero Therapeutics Holdings, Inc.

Cero Therapeutics Holdings, Inc.

OTC: CEROCIK 1870404SOUTH SAN FRANCISCO, CA

Financials

Revenue—
Net income$-19.92M
Total debt$136.8K
Cash$1.90M
Diluted EPS$-18.15
Shares outstanding45.1M

Ownership

45.1M shares outstanding · as of May 14, 2026
4.1%10%+ / strategic
Ownership
10%+ / strategic4.06%1,830,007
Institutions0.00%3
Public float95.94%43,282,396

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Atwood Brian GDirector
——
Byrnes MichaelDirector
——
Ehrlich Christopher BCEOChairman and CEO · Director
——
Kucharchuk Andrew AlbertFormerChief Financial Officer
——
Laporte KathleenDirector
——
Patel ShamiDirector
——
Pierce KristenChief Development Officer
——
Rolfe LindseyDirector
——

Institutional holders 1

View all →
HolderValue% of shares
Bank of America Corp /De$15<0.01%

Activity

Sep 30, 2025View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q4 2025
as of
Bank of America Corp /De
13F manager
ExitCommon Stock$-15-3
-100.00%
0
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Tibbs IsaiahPassive13G—1,830,007—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CEROCommon StockEquity71902K402BBG012LSLG64